A combination of the immunotherapies AM0010 and the immune checkpoint inhibitor pembrolizumab was well tolerated and resulted in durable objective tumor responses in some patients with renal cell carcinoma (RCC) and non-small ...
Sep 27, 2016
Among patients with stage IV melanoma who were being treated with the immunotherapeutic pembrolizumab (Keytruda), the ratio of a particular subset of immune cells in the blood to tumor burden correlated with clinical response, ...
Sep 27, 2016
Heart failure in people with coronary artery disease and simultaneous type 2 diabetes can be prevented with effective treatment. In a large registry study published in The Journal of American College of Cardiology, researchers ...
Sep 27, 2016
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center (CCC) show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved ...
Sep 27, 2016
Poverty and perceived hardship over decades among relatively young people in the U.S. are strongly associated with worse cognitive function and may be important contributors to premature aging among disadvantaged populations, ...
Sep 27, 2016
A new approach to weight loss called Acceptance-Based Behavioral Treatment (ABT) helped people lose more weight and keep it off longer than those who received only Standard Behavioral Treatment (SBT) – a typical treatment ...
Sep 27, 2016
